Recalls put company in regulators’ crosshairs

to the hearts of patients in danger of cardiac arrest. Spokesmen for the Justice Department, the SEC, and Boston Scientific all declined to discuss the federal investigations yesterday. Boston Scientific said March 15 that it had halted shipments and...